UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis

Journal of Immunology, 2006-12, Vol.177 (11), p.8053-8064

2006

Volltextzugriff (PDF)

CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma

PloS one, 2012-03, Vol.7 (3), p.e33005-e33005

2012

Volltextzugriff (PDF)

Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression

Clinical cancer research, 2008-12, Vol.14 (23), p.7717-7725

2008

Volltextzugriff (PDF)

CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog-Driven Medulloblastoma

Cancer research (Chicago, Ill.), 2012-01, Vol.72 (1), p.122-132

2012

Volltextzugriff (PDF)

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11392-11399

2005

Volltextzugriff (PDF)

Fungal pathogen protection in potato by expression of a plant defensin peptide

Nature biotechnology, 2000-12, Vol.18 (12), p.1307-1310

2000

Volltextzugriff (PDF)

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo

Cancer research (Chicago, Ill.), 2007-01, Vol.67 (2), p.651-658

2007

Volltextzugriff (PDF)

Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis

The American journal of pathology, 2008-03, Vol.172 (3), p.799-808

2008

Volltextzugriff (PDF)

Pharmacology of celecoxib in rat brain after kainate administration

The Journal of pharmacology and experimental therapeutics, 2002-09, Vol.302 (3), p.846

2002

Volltextzugriff (PDF)

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (18), p.8588-8595

2007

Volltextzugriff (PDF)

Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth

Molecular cancer research, 2012-01, Vol.10 (1), p.156-166

2012

Volltextzugriff (PDF)

Cyclooxygenase 2‐dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

Arthritis and rheumatism, 2002-07, Vol.46 (7), p.1789-1803

2002

Volltextzugriff (PDF)

Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites

British journal of pharmacology, 2002-02, Vol.135 (4), p.891-900

2002

Volltextzugriff (PDF)

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (5), p.1306-1311

2000

Volltextzugriff (PDF)

Gene isolation and characterization of two acyl CoA oxidases from soybean with broad substrate specificities and enhanced expression in the growing seedling axis

Plant molecular biology, 2001-11, Vol.47 (4), p.519-531

2001

Volltextzugriff (PDF)

Renal effects of selective cyclooxygenase inhibition in experimental liver disease

Advances in experimental medicine and biology, 2003, Vol.525, p.133

2003

Volltextzugriff (PDF)

Cyclooxygenase-2 in human pathological disease

Advances in experimental medicine and biology, 2002, Vol.507, p.177

2002

Volltextzugriff (PDF)

CCR-08-0827 Version 2 Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression

Clinical cancer research, 2008-12, Vol.14 (23), p.7717-7725

2008

Volltextzugriff (PDF)

Analysis of Stained Objects in Histological Sections by Spectral Imaging and Differential Absorption

The journal of histochemistry and cytochemistry, 1999-10, Vol.47 (10), p.1307-1313

1999

Volltextzugriff (PDF)

Cyclooxygenase 2‐dependent prostaglandin E 2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

Arthritis and rheumatism, 2002-07, Vol.46 (7), p.1789-1803

2002

Volltextzugriff (PDF)

Characterization of cyclooxygenase-2 in human pathological disease

Prostaglandins & other lipid mediators, 1999-12, Vol.59 (1), p.233-233

1999

Volltextzugriff (PDF)

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

Diabetologia, 2021-08, Vol.64 (8), p.1822-1833

2021

Volltextzugriff (PDF)

Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland

Archives of disease in childhood. Fetal and neonatal edition, 2012-09, Vol.97 (5), p.F323-F328

2012

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Life Sciences & Biomedicine
(19)
Humans
(13)
Animals
(12)
Biological And Medical Sciences
(10)
Medical Sciences
(9)
Female
(8)
Immunohistochemistry
(8)
Male
(8)
Mice
(8)
Oncology
(7)
Receptors, Cxcr4 - Metabolism
(7)
Neurology
(6)
Antineoplastic Agents
(5)
Brain Neoplasms - Metabolism
(5)
Brain Neoplasms - Pathology
(5)
Cyclooxygenase 2
(5)
Cyclooxygenase Inhibitors - Pharmacology
(5)
Isoenzymes - Metabolism
(5)
Membrane Proteins
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CXCL12 Limits Inflammation by Localizing Mononuclear Infiltrates to the Perivascular Space during Experimental Autoimmune Encephalomyelitis

CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma

Targeted Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression

CXCR4 Activation Defines a New Subgroup of Sonic Hedgehog-Driven Medulloblastoma

Widespread CXCR4 activation in astrocytomas revealed by phospho-CXCR4-specific antibodies

Fungal pathogen protection in potato by expression of a plant defensin peptide

Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo

Pathological Expression of CXCL12 at the Blood-Brain Barrier Correlates with Severity of Multiple Sclerosis

Pharmacology of celecoxib in rat brain after kainate administration

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1

Suppression of G-protein-coupled receptor kinase 3 expression is a feature of classical GBM that is required for maximal growth

Cyclooxygenase 2‐dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

Cyclooxygenase‐1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors

Gene isolation and characterization of two acyl CoA oxidases from soybean with broad substrate specificities and enhanced expression in the growing seedling axis

Renal effects of selective cyclooxygenase inhibition in experimental liver disease

Cyclooxygenase-2 in human pathological disease

CCR-08-0827 Version 2 Targeted inhibition of cyclic AMP phosphodiesterase-4 promotes brain tumor regression

Analysis of Stained Objects in Histological Sections by Spectral Imaging and Differential Absorption

Cyclooxygenase 2‐dependent prostaglandin E 2 modulates cartilage proteoglycan degradation in human osteoarthritis explants

Characterization of cyclooxygenase-2 in human pathological disease

Peripheral immune circadian variation, synchronisation and possible dysrhythmia in established type 1 diabetes

Trends and centre-to-centre variability in survival rates of very preterm infants (<32 weeks) over a 10-year-period in Switzerland

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA 1c , and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Suchergebnisse filtern